Skip to main content
. 2007 Oct 16;97(8):1139–1145. doi: 10.1038/sj.bjc.6604009

Table 2. Immunohistochemical, cytogenetic and molecular data.

Patients EGFR: IHC EGFR: FISH K-Ras: status PTEN: IHC
1 1+ A WT Pos
2 2+ A 13GaC Neg
3 3+ P 12GcT Pos
4 1+ P WT Neg
5 3+ P 12GcT Pos
6 2+ P 12GaT Neg
7 2+ P WT Neg
8 3+ A WT Pos
9 3+ A WT Pos
10 2+ P* WT Pos
11 1+ E 13GaC Neg
12 3+ E 12GaT Pos
13 3+ A WT Pos
14 3+ P* WT Neg
15 2+ A 12tGT Neg
16 2+ P WT Pos
17 1+ A WT Pos
18 2+ P* 12GaT Pos
19 3+ P* WT Neg
20 3+ P 13GaC Pos
21 3+ P 12GaT Pos
22 1+ E WT Pos
23 3+ P WT Neg
24 3+ P WT Neg
25 3+ A WT Pos
26 2+ P* WT Pos
27 2+ P WT Neg
Total 5/27 (19%) score 1+ 8/27 (30%) A 17/27 (63%) WT 16/27=59% Pos
  9/27 (33%) score 2+ 16/27 (59%) P 10/27 (37%) Mutated 11/27=42% Neg
  13/27 (48%) score 3+ 3/27 (11%) E    

Abbreviations: A, EGFR gene amplification; P, chromosome 7 polysomy; P*, polysomy with rare cells showing EGFR amplification; E, eusomy; WT, wild type; Pos, positive; Neg, negative.